Hide Board Information

Show Board Information

PRYSMIAN SPA EUR0.10 0NUX

Board Mod: Add me as mod

Asst Mods:

Last Post: 06/04/2012 2:03:26 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

PRYSMIAN SPA EUR0.10 (0NUX) Stock Message Board

Find 0NUX Recent News, 0NUX Filings, 0NUX Stock Quote, 0NUX Stock Chart, 0NUX Research & Opinions Below

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on PRYSMIAN SPA EUR0.10 0NUX

Recent Articles

• VAALCO Energy Enhances Exploration with New Rig Agreement
• Endeavour Mining's Assafou Project: Promising PFS Outcomes
• Endeavour Mining Unveils Promising PFS Findings for Assafou Project
• Bigbank Unveils Convenient New Current Account for Customers
• INVL Technology's Comprehensive Investor Outlook for 2025
• PayPoint plc Progresses with Strategic Share Buyback Program
• Understanding Significant Holdings at Intermediate Capital Group
• Upcoming 2025 Schedule for INVL Baltic Real Estate Announced
• Anoto Group Extends Subscription Period for Rights Issue
• FTI Consulting Expands Expertise with Key Appointments in Construction
• Faraday Future Enhances Manufacturing by Insourcing Seat Production
• Microip's Stock Debut Marks a New Era in Semiconductor Design
• Broadridge Partners with First Abu Dhabi Bank for Growth
• Workday's New AI Innovations Enhance Employee Engagement & Insights
• Syrebo Partners with Quality Production to Boost Rehab Tech
• Allegro NV's Innovative Gel Shows Safety in Joint Therapy Trials
• Exploring the Expanding Handyman Service Market Potential
• Binance and Circle Unite to Boost USDC Usage Globally
• Viva Biotech Expands Global Reach with New Boston Branch
• Revolutionizing Rehab: Syrebo's Robotics Reshape Therapy
• Bayport Management Ltd Strengthens Financial Position with Refinancing
• BW LPG Limited Ex-Dividend Announcement for Shareholders Today
• Leading Spain Programmatic Ad Sellers for Q3 2024 Unveiled
• Santhera's AGAMREE Receives NMPA Approval for DMD Treatment
• Sanofi's New Vaccine Candidate Receives Fast Track Status
• Kerecis Expands Its Innovative Medical Frontiers in Europe
• Exciting New Developments in Pediatric Clinical Trials for Leniolisib
• Coop Pank Thrives With Robust November Financial Results
• Red Eléctrica Embraces Innovation with Dassault's 3DEXPERIENCE
• Red Eléctrica's Innovative Shift with Dassault Systèmes’ 3DEXPERIENCE
• BenevolentAI's Strategic Transformations for Future Success
• CJ 4DPLEX and EVT Join Forces to Elevate Cinema in Australia
• Syrebo's Cutting-Edge Rehabilitation Robots Debut at MEDICA 2024
• HDFN Awareness Initiative Launched in Africa by BSV
• BioVaxys Technology Corp. Reduces Private Placement Unit Pricing
• EcoFlow Launches Innovative Program for Sustainable Lifestyle Advocates
• Boardwalk Pipelines Approves Major Investment in Pipeline Project
• CROSSFIRE Animation Launch on Prime Video: An Exciting Update
• Feintool Partners in Hydrogen Mobility with Major Order in China
• TECNO Collaborates with Universities to Enhance Skin Tone Technology
• Quantum Computing, Inc. Secures $50 Million Through Stock Offerings
• VersiFi Receives Approval for Digital Asset Trading Solutions
• Surgo Health Delivers a Pioneering Tool for Youth Mental Wellbeing
• Exploring the $32 Trillion Market Opportunity for Women-Centric Services
• The Urgent Need for Climate Action to Safeguard Profits
• China Seizes Majority of Global EV Traction Inverter Market
• Nokia and SK Broadband Enhance Security for Energy Infrastructure
• Highlights from the 2024 Global Pitch Competition Finale
• Exciting Developments with the Launch of LF India
• Harmony of Tradition and Modernity: The Artistry of Vincent Fang